Dora R. Tabachnick

Dora R. Tabachnick

Auto-generated profile, based on publicly available information

Dora R. Tabachnick

School of Medicine, Rosalind Franklin School of Medicine, North Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2021 in Neuron
Verified
Journal Article
Closed access
JCJiayang Chen
Jiayang Chen
MLMary E. Lambo
Mary E. Lambo
XGXia Ge
Xia Ge
JDJoshua T. Dearborn
Joshua T. Dearborn
YLYating Liu
Yating Liu
JDJoseph D. Dougherty
Joseph D. Dougherty

6 July 2026 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Open access
MGMohammad Ghorbani
Mohammad Ghorbani
DTDora Tabachnick
Dora Tabachnick
ERElham Rahmanipour
Elham Rahmanipour
ATArian Tavasol
Arian Tavasol
KGKhushal Gupta
Khushal Gupta
MKMichael Karsy
Michael Karsy
Ischemic stroke remains a leading cause of death in the United States, with the COVID-19 pandemic exacerbating disparities. Prior studies have been limited by small sample sizes and lack of generalizability. We used nationally representative data to assess the effects of COVID-19 on ischemic stroke care, outcomes, and predictive modeling. We performed a retrospective cohort study using the 2019-2021 HCUP National Inpatient Sample (NIS). Ischemic stroke hospitalizations and COVID-19 diagnosis were identified using ICD-10-CM diagnosis codes. Hospitalizations were categorized as pre-pandemic calendar year 2019 versus pandemic-era 2020-2021. Calendar-defined pandemic epochs were evaluated as temporal phases and were not interpreted as patient-level SARS-CoV-2 variant assignments. Survey-weighted analyses and machine-learning models were used to evaluate in-hospital mortality. We identified 517,750 weighted ischemic stroke hospitalizations. Compared with the pre-pandemic year 2019, the pandemic era (2020-2021) had higher in-hospital mortality, slightly longer length of stay, higher total hospital charges, and shifted discharge disposition patterns. IV/IA thrombolysis-coded procedure rates were similar between eras, whereas mechanical endovascular reperfusion-coded procedures were more frequent during the pandemic. In the expanded survey-weighted mortality model, COVID-19 diagnosis was associated with higher in-hospital mortality (aOR 2.74, 95% CI 2.42-3.11). Most calendar-defined pandemic epochs were not independently associated with mortality, although the 2021Q4 Delta-to-Omicron transition epoch showed a modest association. In the NIHSS-coded subgroup, COVID-19 diagnosis remained associated with mortality after NIHSS adjustment. Admission-time machine-learning models showed modest discrimination, with AUROC values ranging from 0.62 to 0.64 and AUPRC values ranging from 0.12 to 0.14. COVID-19 diagnosis was strongly associated with in-hospital mortality after ischemic stroke, whereas broad calendar-defined pandemic timing alone showed limited independent association. Calendar epochs should not be interpreted as variant-specific effects because NIS lacks patient-level SARS-CoV-2 sequencing, viral subtype, or variant data. Admission-time machine-learning models provided modest mortality prediction and require cautious interpretation.